Global HMO Milk Powder Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

The global HMO Milk Powder market size was US$ 4200 million in 2025 and is forecast to reach a readjusted size of US$ 8633 million by 2032 with a CAGR of 11.0% during the forecast period 2026-2032.

HMO Milk Powder refers to infant formula enriched with Human Milk Oligosaccharides (HMOs), which are complex carbohydrates naturally found in human breast milk. HMOs play a crucial role in infant nutrition and overall health by promoting gut microbiome development, strengthening the immune system, and preventing infections. These oligosaccharides are not fully digestible by infants, but they serve as prebiotics that selectively support the growth of beneficial bacteria in the gut, thereby enhancing overall health.

HMO milk powder products are designed to replicate the nutritional composition of breast milk as closely as possible, especially for infants who are unable to be breastfed. They are typically available in various stages to match the different nutritional needs of infants as they grow. These stages include:

Stage 1 (0-6 months): Formulas in this category are designed to be the sole source of nutrition for newborns, aiming to closely mimic the composition of breast milk. They typically contain a balanced mix of proteins, fats, carbohydrates, vitamins, and minerals to support rapid growth and development.

Stage 2 (6-12 months): At this stage, infants begin to consume solid foods, but formula continues to be a significant part of their diet. Stage 2 HMO formulas provide additional nutrients to support cognitive development, immune health, and the overall physical growth of the infant.

Stage 3 (12 months and above): Formulas for older infants are designed to provide higher levels of energy, vitamins, and minerals to meet the nutritional needs of toddlers who are more active and have a higher metabolic rate.

HMO milk powder is regarded as a premium product, with its key selling point being the presence of these oligosaccharides, which are believed to provide benefits similar to those of breast milk. HMOs in milk powder are often derived through advanced biotechnological processes such as fermentation, making them available to a wider population of infants globally. The range of HMOs included in these formulas can vary, with some brands incorporating specific types like 2'-fucosyllactose, which is known for its immunological benefits.

The growth of the HMO milk powder market is driven by the increasing demand for infant formulas that can support healthy immune development, gut health, and overall growth, especially in regions where access to breastfeeding is limited or where working mothers prefer formula feeding. As awareness about the benefits of HMOs increases, more parents are opting for these premium formulas over regular infant formulas.

Market Development Opportunities: The global market for HMO milk powder has seen significant growth in recent years, with increased demand for premium infant formulas containing human milk oligosaccharides. This demand is particularly high in developing regions like China, Southeast Asia, and India, where the middle class is expanding and there is an increasing awareness about the importance of infant nutrition. Parents in these regions are becoming more conscious of the nutritional quality of infant formula, especially in light of the growing concerns about food safety and the health benefits of breast milk substitutes.

The rise of e-commerce and online shopping platforms has also expanded market access, allowing brands to reach more consumers globally. As more parents research the nutritional value of infant formulas, they are more likely to choose products that offer advanced formulations like HMO-based milk powders. The growing preference for convenience, coupled with the desire for better nutrition, presents substantial market opportunities for HMO milk powder manufacturers.

Key Drivers:

Health and Wellness Awareness: As parents increasingly seek to provide the best possible nutrition for their children, awareness of the benefits of HMO in infant nutrition has surged. HMOs are believed to enhance immune function, support brain development, and improve gut health, making them highly desirable.

Technological Advancements in HMO Production: The development of advanced biotechnologies, such as fermentation processes for HMO production, has made it more cost-effective to incorporate these beneficial oligosaccharides into infant formulas. This has driven the proliferation of HMO milk powders in the market.

Increased Working Mothers: With more mothers returning to work after childbirth, formula feeding has become a more practical solution for many families. The demand for high-quality, nutritious formulas has risen as a result.

Risks:

Regulatory Challenges: The infant formula industry is highly regulated, with strict guidelines regarding product claims and nutritional content. HMO milk powders, particularly those making health claims about immune support or brain development, face intense scrutiny from regulatory bodies. Any failure to comply with these regulations could harm a brand’s reputation and market position.

Supply Chain and Production Costs: The production of HMOs still relies on specialized biotechnologies that can be expensive. Any disruptions in the supply chain or fluctuations in raw material costs could affect production and pricing. Moreover, scaling up HMO production to meet demand could involve significant investment and operational challenges.

Consumer Skepticism: While HMOs are marketed as a key component of premium infant formulas, some parents remain skeptical about the long-term benefits of these added ingredients. Additionally, the growing demand for organic and natural products could lead to concerns about the artificial nature of HMO production.

Market Concentration: The market for HMO milk powders is largely concentrated among a few dominant players, such as Nestlé, Danone, Abbott, and Mead Johnson. These multinational corporations have the resources to invest in research and development and have established brand recognition and distribution networks. However, smaller brands that specialize in HMO-enriched formulas are also emerging, targeting niche markets or specific consumer segments looking for specialized nutritional products.

Downstream Demand Trends: The demand for premium, nutritionally advanced milk formulas, including those with HMO, is expected to continue to grow as parents increasingly prioritize infant health and seek products that can enhance immune system development, gut health, and cognitive function. There is also a growing interest in transparency and ethical sourcing, with more consumers preferring organic, non-GMO, and sustainably sourced ingredients in their children’s products. As parents seek more information on the nutritional content and production processes of infant formulas, brands will need to provide greater transparency in their marketing and product labeling.

Latest Technologies: The production of HMOs has benefited from significant advances in biotechnology, particularly through fermentation processes that allow for more efficient and cost-effective production of these oligosaccharides. This has made it feasible to include HMOs in infant formulas without significantly raising costs. Additionally, the use of nanoencapsulation and other advanced delivery technologies is being explored to enhance the bioavailability and absorption of HMOs, ensuring that infants can derive the maximum benefit from these added ingredients. Furthermore, research into the specific effects of various types of HMOs (e.g., 2'-fucosyllactose and lacto-N-neotetraose) continues to reveal new insights into their potential health benefits, driving further innovation in the formulation of infant milk powders.

In conclusion, the HMO milk powder market presents significant opportunities for growth, driven by the increasing demand for advanced infant nutrition. However, manufacturers must navigate regulatory hurdles, supply chain challenges, and consumer skepticism to capitalize on these opportunities. The integration of cutting-edge biotechnologies and a focus on transparency and consumer education will be crucial to success in this rapidly expanding market.

The global HMO Milk Powder market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.